World Health Organization (1968) Nutritional anemia: report of a WHO Scientific Group. World Health Organization, Geneva
Peng Y, Dong B, Wang Z (2016) Serum folate concentrations and all-cause, cardiovascular disease and cancer mortality: a cohort study based on 1999–2010 National Health and Nutrition Examination Survey (NHANES). Int J Cardiol 15(219):136–142. https://doi.org/10.1016/j.ijcard.2016.06.024 (Epub 2016 Jun 15)
Ferrucci L, Guralnik JM, Bandinelli S et al (2007) Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers. Br J Haematol 136:849–855
Article PubMed PubMed Central CAS Google Scholar
Castelli R, Schiavon R, Deliliers GL (2018) The impact of anemia, transfusion dependency, comorbidities and polypharmacy in elderly patients with low-risk myelodysplastic syndromes. Med Oncol 35(3):33. https://doi.org/10.1007/s12032-018-1094-7
Chaves PHM, Ashar B, Guralnik JM, Fried LP (2002) Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women: should the criteria currently used to define anemia in older people be reevaluated? J Am Geriatr Soc 50:1257–1264
Migone De Amicis M, Poggiali E, Motta I et al (2015) Anemia in elderly hospitalized patients: prevalence and clinical impact. Intern Emerg Med 10:581–586
Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM (2001) Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345:1230–1236
Article PubMed CAS Google Scholar
Carneiro AV (2023) Unwarranted clinical practice variation and resource overutilization in medical care: the example of transfusion practices in elderly hospital patients. Eur J Intern Med 115:43–45. https://doi.org/10.1016/j.ejim.2023.07.020 (Epub 2023 Jul 21)
Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, Mountzios G, Peswani N, Porter L, Tanaka TN, Trifirò G, Yang H, Lazo-Langner A (2019) Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH Clinical Practice Guideline update. J Clin Oncol 37(15):1336–1351. https://doi.org/10.1200/JCO.18.02142 (Epub 2019 Apr 10)
Article PubMed CAS Google Scholar
Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, Mountzios G, Peswani N, Porter L, Tanaka TN, Trifirò G, Yang H, Lazo-Langner A (2019) Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update. Blood Adv 3(8):1197–1210. https://doi.org/10.1182/bloodadvances.2018030387
Article PubMed PubMed Central Google Scholar
Castelli R, Schiavon R, Rossi V, Deliliers GL (2018) Management of anemia in low-risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents. Med Oncol 35(5):76. https://doi.org/10.1007/s12032-018-1135-2
Article PubMed CAS Google Scholar
Castelli R, Deliliers GL, Colombo R, Moreo G, Gallipoli P, Pantaleo G (2014) Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function. Ann Hematol 93(9):1523–1529. https://doi.org/10.1007/s00277-014-2070-8 (Epub 2014 Apr 8)
Article PubMed CAS Google Scholar
Castelli R, Sciara S, Lambertenghi Deliliers G, Pantaleo G (2017) Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study. Ann Hematol 96(5):779–786. https://doi.org/10.1007/s00277-017-2950-9 (Epub 2017 Mar 2)
Article PubMed CAS Google Scholar
Miura T, Sato T, Yano T, Takaguri A, Miki T, Tohse N, Nishizawa K (2023) Role of erythropoiesis-stimulating agents in cardiovascular protection in CKD patients: reappraisal of their impact and mechanisms. Cardiovasc Drugs Ther 37(6):1175–1192. https://doi.org/10.1007/s10557-022-07321-3 (Epub 2022 Feb 12)
Article PubMed CAS Google Scholar
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA, Cardiovascular Health Study Collaborative Research Group (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156. https://doi.org/10.1093/gerona/56.3.m146
Article PubMed CAS Google Scholar
Hamaker ME, Jonker JM, de Rooij SE, Vos AG, Smorenburg CH, van Munster BC (2012) Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol 13(10):e437–e444. https://doi.org/10.1016/S1470-2045(12)70259-0
Patel SK, Griggs MR, Ghoneim YM, Malhotra CK, Fenves AZ, Jacob SC (2020) Evaluation of the use of erythropoietin-stimulating agents in a hospital setting to assess the necessity of a protocol-driven anemia management service. Proceedings (Bayl Univ Med Cent) 33(2):191–194. https://doi.org/10.1080/08998280.2020.1723360
Gowanlock Z, Sriram S, Martin A, Xenocostas A, Lazo-Langner A (2017) Erythropoiesis-stimulating agents in elderly patients with anemia: response and cardiovascular outcomes. Blood Adv 1(19):1538–1545. https://doi.org/10.1182/bloodadvances.2017007559
Article PubMed PubMed Central CAS Google Scholar
Lee L, Patel T, Costa A, Bryce E, Hillier LM, Slonim K, Hunter SW, Heckman G, Molnar F (2017) Screening for frailty in primary care: accuracy of gait speed and hand-grip strength. Can Fam Physician 63(1):e51–e57
PubMed PubMed Central Google Scholar
Beauchet O, Fantino B, Allali G, Muir SW, Montero-Odasso M, Annweiler C (2011) Timed Up and Go test and risk of falls in older adults: a systematic review. J Nutr Health Aging 15(10):933–938. https://doi.org/10.1007/s12603-011-0062-0
Article PubMed CAS Google Scholar
Weiss G, Ganz T, Goodnough LT (2019) Anemia of inflammation. Blood 133(1):40–50. https://doi.org/10.1182/blood-2018-06-856500 (Epub 2018 Nov 6)
Article PubMed PubMed Central CAS Google Scholar
Patel VJ, Joharapurkar AA, Kshirsagar SG, Patel MS, Savsani HH, Rakhasiya MH, Dodiya HS, Jain MR (2024) Inhibition of alternative complement system and prolyl hydroxylase ameliorates anaemia of inflammation. Inflammopharmacology. https://doi.org/10.1007/s10787-024-01592-y (Epub ahead of print)
Fayed B, Luo S, Yassin AEB (2024) Challenges and recent advances in erythropoietin stability. Pharm Dev Technol. https://doi.org/10.1080/10837450.2024.2410448 (Epub ahead of print)
Marengoni A, Bonometti F, Nobili A, Tettamanti M, Salerno F, Corrao S, Iorio A, Marcucci M, Mannucci PM, Italian Society of Internal Medicine (SIMI) Investigators (2010) In-hospital death and adverse clinical events in elderly patients according to disease clustering: the REPOSI study. Rejuvenation Res 13(4):469–477. https://doi.org/10.1089/rej.2009.1002
Article PubMed CAS Google Scholar
Wacka E, Wawrzyniak-Gramacka E, Tylutka A, Morawin B, Gutowicz M, Zembron-Lacny A (2023) The role of inflammation in age-associated changes in red blood system. Int J Mol Sci 24(10):8944. https://doi.org/10.3390/ijms24108944
Article PubMed PubMed Central CAS Google Scholar
Chang SS, Weiss CO, Xue QL, Fried LP (2012) Association between inflammatory-related disease burden and frailty: results from the Women’s Health and Aging Studies (WHAS) I and II. Arch Gerontol Geriatr 54(1):9–15. https://doi.org/10.1016/j.archger.2011.05.020 (Epub 2011 Jul 16)
Veronese N, Cereda E, Stubbs B, Solmi M, Luchini C, Manzato E, Sergi G, Manu P, Harris T, Fontana L, Strandberg T, Amieva H, Dumurgier J, Elbaz A, Tzourio C, Eicholzer M, Rohrmann S, Moretti C, D’Ascenzo F, Quadri G, Polidoro A, Lourenço RA, Moreira VG, Sanchis J, Scotti V, Maggi S, Correll CU (2017) Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: results from a meta-analysis and exploratory meta-regression analysis. Ageing Res Rev 35:63–73. https://doi.org/10.1016/j.arr.2017.01.003 (Epub 2017 Jan 28)
Article PubMed PubMed Central Google Scholar
Cody J, Daly C, Campbell M, Donaldson C, Grant A, Khan I, Vale L, Wallace S, MacLeod A (2002) Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003895 (Update in: Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003895. 10.1002/14651858.CD003895.pub2)
Comments (0)